Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kodiak Sciences Inc.
Market Cap
$5.78B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.79B
Operating Margin
-153.08%
TTM Avg
-197.00%
3Y Avg
-9782.25%
5Y Avg
-6521.50%
Market Cap
$5.87B
Operating Margin
11.92%
TTM Avg
0.31%
3Y Avg
-1.06%
5Y Avg
-68.44%
Market Cap
$5.89B
Operating Margin
-362.95%
TTM Avg
-1052.99%
3Y Avg
-3382.94%
5Y Avg
-3698.56%
Market Cap
$5.61B
Operating Margin
-4722.13%
TTM Avg
-7394.69%
3Y Avg
-15105.91%
5Y Avg
-12109.07%
Market Cap
$5.95B
Operating Margin
17.61%
TTM Avg
2.04%
3Y Avg
3.68%
5Y Avg
13.44%
Market Cap
$5.52B
Operating Margin
0.53%
TTM Avg
-2.93%
3Y Avg
-2.93%
5Y Avg
-2.93%
Market Cap
$6.23B
Operating Margin
-101.19%
TTM Avg
-152.62%
3Y Avg
-325.31%
5Y Avg
-1115.52%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.78B | 0.00% | 0.00% | 0.00% | 0.00% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -153.08% | -197.00% | -9782.25% | -6521.50% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 11.92% | 0.31% | -1.06% | -68.44% |
| GRAIL Inc. (GRAL)vs › | $5.89B | -362.95% | -1052.99% | -3382.94% | -3698.56% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -4722.13% | -7394.69% | -15105.91% | -12109.07% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 17.61% | 2.04% | 3.68% | 13.44% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 4.00% | 5.08% | 4.88% | 4.85% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 0.53% | -2.93% | -2.93% | -2.93% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | -101.19% | -152.62% | -325.31% | -1115.52% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 49.49% | 6.00% | -24.72% | -46.97% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
